Targeting PTK6 to the plasma membrane by addition of a palmitoylation/myristoylation signal promoted the epithelial mesenchymal transition and enhanced growth and metastasis of prostate cancer xenograft tumors [11]. Here, PTK6 is linked to prostate carcinoma.